Seminars in Radiation Oncology
Volume 20, Issue 2 , Pages 121-129, April 2010

Adaptive Management of Cervical Cancer Radiotherapy

  • Kari Tanderup, PhD

      Affiliations

    • Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • ,
  • Dietmar Georg, DSc

      Affiliations

    • Department of Radiotherapy, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationAddress reprint requests to Dietmar Georg, DSc, Department of Radiotherapy, Medical University Vienna, AKH Wien, Währinger Gürtel 18–20, A-1090 Vienna, Austria
  • ,
  • Richard Pötter, MD

      Affiliations

    • Department of Radiotherapy, Medical University of Vienna, Vienna, Austria
  • ,
  • Christian Kirisits, DSc

      Affiliations

    • Department of Radiotherapy, Medical University of Vienna, Vienna, Austria
  • ,
  • Cai Grau, DMSc, MD

      Affiliations

    • Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • ,
  • Jacob C. Lindegaard, DMSc, MD

      Affiliations

    • Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

Since the breakthrough 10 years ago with concomitant radio-chemotherapy, substantial progress in the treatment of locally advanced cervical cancer has been lacking. Radiotherapy continues to be the cornerstone in the treatment of this disease and now shows much potential for progress, as image guidance of both external beam radiation therapy and brachytherapy, linked with strong tools for treatment planning and dose delivery, is becoming available. With these new techniques, it again seems possible to improve the therapeutic ratio as we begin to understand how the treatment for each patient can be individualized, not only in terms of volume (3-dimensional), but also during treatment (4-dimensional), as the tumor regresses and the topography of the target and organs at risk change significantly. New promising data with increased loco-regional control and decreased morbidity compared with the past are appearing. At the dawn of this new era, it is the aim of the present article to give an overview of the use of image-guided adaptive radiotherapy in the multimodal management of locally advanced cervical cancer.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Competing interests. The Department of Radiotherapy at the Medical University of Vienna received financial and/or equipment support for research and educational purposes from Nucletron BV, Varian Medical Systems, Isodose Control BV, and ELEKTA. The Department of Oncology at Aarhus University Hospital received financial and/or equipment support for research and educational purposes from Varian Medical Systems.

 Aarhus University Hospital was supported by research grants from the Danish Cancer Society, Varian Medical Systems, Palo Alto, California, Danish Council for Strategic Research, and CIRRO—the Lundbeck Foundation Centre for Interventional Research in Radiation Oncology.

PII: S1053-4296(09)00080-0

doi:10.1016/j.semradonc.2009.11.006

Seminars in Radiation Oncology
Volume 20, Issue 2 , Pages 121-129, April 2010